Tibet Aim Pharm Inc (002826)

Shenzhen

Currency in CNY

23.35

-0.15(-0.64%)

Closed·15/08

Fair Value

Unlock Value

Day's Range

22.67

24.30

52 wk Range

7.53

25.60

002826 Financial Summary

A brief financial summary of Tibet Aim Pharm Inc as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio112.45

Price/Book5.55

Debt / Equity4.6%

Return on Equity5.04%

Dividend Yield0.43%

EBITDA48.82M

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2022

01/01

2023

01/01

2023

31/12

2024

31/12

Income Statement

Total Revenues

aa.aa

602.62

725.46

856.73

667.04

651.88

Gross Profit

aa.aa

216.6

260.5

376.03

341.45

446.34

Operating Income

aa.aa

39.2

41.58

46.32

24.91

27.26

Net Income

aa.aa

41.09

42.48

44.14

15.39

45.93

Balance Sheet

Total Assets

aa.aa

908.09

824.47

1,018.2

927.74

926.47

Total Current Liabilities

aa.aa

218.27

99.35

261.91

171.08

175.12

Total Equity

aa.aa

687.15

720.11

750

750.06

745.58

Cash Flow

Levered Free Cash Flow

aa.aa

37.13

12.88

88.29

135.69

22.04

Cash from Operations

aa.aa

101.74

109.52

68.45

166.88

111.57

Cash from Investing

aa.aa

-7.85

-53.68

-1.72

-43

Cash from Financing

aa.aa

-46.78

-59.2

27.59

-59.3

-44.26

Net Change in Cash

aa.aa

47.03

-3.38

94.31

64.57

86.54

* In Millions of CNY (except for per share items)

Dividends

Payout Ratio

Payout ratio (TTM)

Earnings retained

EPS 0.20%

Dividend Yield

0.43%

Industry Median 1.50%

Annualised payout

0.10

Paid annually

5-Years Growth

+20.11%

Growth Streak

Unlock

Earnings

Latest Release

Apr 24, 2025

EPS / Forecast

0.10 / --

Revenue / Forecast

148.53M / --

EPS Revisions

Unlock

Last 90 days

FAQ

What were Tibet Aim Pharm's earnings for the latest quarter?

The Tibet Aim Pharm EPS (TTM) is 0.20. Tibet Aim Pharm reported sales of 148.53, net income of 18.79, and EPS of 0.10 for the latest quarter.

What was Tibet Aim Pharm's net income for the latest quarter?

Tibet Aim Pharm's net income for the latest quarter was 18.79.

How did Tibet Aim Pharm's performance compare year-over-year in the latest quarter?

The company's revenue moved from 139.04 in the previous quarter to 148.53 in the latest quarter, and net income moved from 4.11 to 18.79 compared to the previous quarter.

What is Tibet Aim Pharm's net profit margin on a TTM basis?

Tibet Aim Pharm's trailing twelve months (TTM) net profit margin is 7.05%.

How does Tibet Aim Pharm's debt to equity ratio compare to industry standards?

Tibet Aim Pharm's total debt-to-equity ratio is 4.60%.

What is Tibet Aim Pharm's return on investment on a TTM basis?

Tibet Aim Pharm's trailing twelve months (TTM) return on investment (ROI) is 5.04%.

Did Tibet Aim Pharm gain or lose cash last quarter?

In the latest quarter, Tibet Aim Pharm's net change in cash was -134.87 million.

What were Tibet Aim Pharm's total assets and liabilities in the latest quarter?

As of the latest quarter, Tibet Aim Pharm reported total assets of 986.51 million and total liabilities of 213.40 million.

How has Tibet Aim Pharm's total revenue grown this year?

Tibet Aim Pharm's total revenue was 139.04 in the previous quarter and 148.53 in the latest quarter.

What is Tibet Aim Pharm's gross margin on a TTM basis?

Tibet Aim Pharm's trailing twelve months (TTM) gross margin is 73.18%.

What was Tibet Aim Pharm's revenue per share for the latest quarter?

Tibet Aim Pharm's revenue per share for the latest quarter was 6.94.

NSE 30

5,282.27

-20.65

-0.39%

NSE All Share

144,628.20

-738.83

-0.51%

US 30

44,923.30

+12.0

+0.03%

US 500

6,446.80

-21.7

-0.34%

FTSE 100

9,138.90

-38.34

-0.42%

DAX

24,359.30

-18.20

-0.07%

South Africa Top 40

94,498.38

-67.81

-0.07%

Market Movers

Name	Last	Chg. %	Vol.
Aiico	3.80	-9.31%	118.00M
Ellah Lakes	14.88	-6.42%	34.24M
First HoldCo	32.85	0.00%	23.96M
Guaranty Trust Holding	97.70	+0.51%	20.67M
UBA	48.00	-0.62%	13.99M
Zenith Bank	72.40	+0.56%	13.81M
Lafarge Africa	138.00	0.00%	5.07M

Name	Last	Chg. %	Vol.
Mutual Benefits Assurance	3.85	+10.00%	102.42M
Ikeja	22.650	+9.95%	4.00M
Wema Bank	22.75	+9.90%	2.11M
Deap Capital Management Trust	1.61	+9.52%	5.87M
Tripple Gee and Co	5.60	+8.32%	483.48K
Dangote Sugar	55.95	+6.57%	3.19M
Fidson	43.900	+5.91%	805.81K

Name	Last	Chg. %	Vol.
Linkassure	2.43	-10.00%	50.01M
International Energy Insurance	3.33	-10.00%	4.58M
Lasaco Assurance PLC	4.05	-10.00%	52.85M
Nem	32.500	-9.97%	607.38K
Meyer	16.75	-9.95%	300.54K
Regal Insurance	1.36	-9.93%	46.96M
Coronation Insurance	3.63	-9.93%	28.60M

Trending Stocks

Name	Last	Chg. %	Vol.
UBA	48.00	-0.62%	13.99M
Access Holdings	27.95	+1.08%	10.81M
Transcorp	50.100	+0.10%	2.33M
Fidelitybk	20.950	-0.24%	19.39M
Zenith Bank	72.40	+0.56%	13.81M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaa	5,379.30	+51.62%	8,156.09
Aaaa A Aaaa Aaa	1,890.00	+34.95%	2,550.56
Aaaaaaa Aaa	577.00	+31.20%	757.02
Aaaaaaaaaaaaaaaa	71.00	+19.11%	84.57
A Aaaa Aaaa	168.60	+13.65%	191.61

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Tibet Aim Pharm Inc (002826)

002826 Financial Summary

Key Ratios

Statements Highlights

Dividends

Earnings

FAQ

What were Tibet Aim Pharm's earnings for the latest quarter?

What was Tibet Aim Pharm's net income for the latest quarter?

How did Tibet Aim Pharm's performance compare year-over-year in the latest quarter?

What is Tibet Aim Pharm's net profit margin on a TTM basis?

How does Tibet Aim Pharm's debt to equity ratio compare to industry standards?

What is Tibet Aim Pharm's return on investment on a TTM basis?

Did Tibet Aim Pharm gain or lose cash last quarter?

What were Tibet Aim Pharm's total assets and liabilities in the latest quarter?

How has Tibet Aim Pharm's total revenue grown this year?

What is Tibet Aim Pharm's gross margin on a TTM basis?

What was Tibet Aim Pharm's revenue per share for the latest quarter?

Trending Stocks